3rd Quarter - Report
HOLLAND & KNIGHT LLP for UNITED MITOCHONDRIAL DISEASE FOUNDATION
Firm
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT HUNT BRADNER | — |
| MIRANDA FRANCO | — |
| SARAH STARLING CROSSAN | — |
Budget/Appropriations BUD
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT HUNT BRADNER | — |
| MIRANDA FRANCO | — |
| SARAH STARLING CROSSAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.